Stay updated on Isatuximab Combo in High-Risk Smoldering MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.

Latest updates to the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page
- Check2 days agoChange DetectedRevision history updated: added v3.4.2 and removed v3.4.1, with no impact on core content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page history shows a new Revision: v3.4.1 and the removal of Revision: v3.4.0, reflecting a minor version update in the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedSmall UI and release-note updates were made on the history page, including a 'Show glossary' option, color-diff guidance (green for additions, red for deletions), and a new Revision: v3.4.0, along with the removal of the No FEAR Act data reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check30 days agoChange DetectedThe history page shows a new revision entry v3.3.4 replacing the previous v3.3.3.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history page shows a new revision entry 'Revision: v3.3.3' and removes the 'HHS Vulnerability Disclosure' link and the earlier 'Revision: v3.3.2' entry from the footer, which are administrative, non-content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedA References section and an updated Study Status were added, with a new version entry (33) appearing on 2025-12-05.SummaryDifference0.3%

Stay in the know with updates to Isatuximab Combo in High-Risk Smoldering MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.